Crinetics Pharmaceuticals, Inc. (CRNX) Operating cash flow 2016–2025
Crinetics Pharmaceuticals, Inc. (CRNX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$377.9MFY2025 · since FY2016: -$5.5M → -$377.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$377.9M | -64.2% |
| FY2024 | -$230.2M | -36.5% |
| FY2023 | -$168.6M | -46.3% |
| FY2022 | -$115.2M | -30.0% |
| FY2021 | -$88.6M | -42.8% |
| FY2020 | -$62.0M | -33.7% |
| FY2019 | -$46.4M | -138.4% |
| FY2018 | -$19.5M | -105.3% |
| FY2017 | -$9.5M | -73.4% |
| FY2016 | -$5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice